MFS
VIR icon

Mirabella Financial Services’s Vir Biotechnology VIR Stock Holding History

Mirabella Financial Services’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151K Buy
+16,856
New +$134K 0.01% 820
2023
Q3 		– Sell
-412,008
Closed -$10.1M – 635
2023
Q2 		$10.1M Buy
+412,008
New +$10.3M 1.11% 11
2022
Q2 		– Sell
-61,137
Closed -$1.57M – 726
2022
Q1 		$1.57M Buy
+61,137
New +$1.81M 0.17% 116
2020
Q4 		– Sell
-29,130
Closed -$1M – 492
2020
Q3 		$1M Buy
+29,130
New +$1.25M 0.14% 87

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Mirabella Financial Services's VIR Position: Q1 2026 in Review

Mirabella Financial Services opened a new position in Vir Biotechnology (VIR) in Q1 2026: 16,856 shares worth $151K. The stake represents 0.01% of the portfolio and ranks #820 among its holdings. This is a return to the name: Mirabella Financial Services previously reported a position in VIR as recently as Q2 2023.

Mirabella Financial Services first reported a position in VIR in Q3 2020 and has held it in 4 quarters since. The position peaked at $10.1M in Q2 2023. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Mirabella Financial Services held 16,856 shares of Vir Biotechnology worth $151K as of Q1 2026.
  • Vir Biotechnology was a new Mirabella Financial Services position in Q1 2026.
  • Vir Biotechnology made up 0.01% of Mirabella Financial Services's portfolio in Q1 2026, its #820 holding.
  • Mirabella Financial Services first reported a position in Vir Biotechnology in Q3 2020 and has held it in 4 quarters since.
  • Mirabella Financial Services's Vir Biotechnology position peaked at $10.1M in Q2 2023.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Mirabella Financial Services's 13F filing for Q1 2026, filed 12 May 2026.